ANDABAKA, M. et al. NEUROMYELITIS OPTICA SPECTRUM DISORDERS: THERAPEUTIC CONSIDERATIONS: NMOSD therapeutic considerations. Medical Research, v. 58, n. 1, 18 Feb.2025.